EIF2C2 (AGO2) transcript presents contrasting regulation depending on the cell line whereas EIF2C4 (AGO4) appears to be up-regulated in two other cell lines (HUVEC and prostate cancer at 48 h and 72 h of hypoxia, respectively. Here, AGO2 is linked to prostate carcinoma.